News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
883,859 Results
Type
Article (88780)
Company Profile (816)
Press Release (794241)
Multimedia
Podcasts (238)
Webinars (35)
Section
Business (233592)
Career Advice (4162)
Deals (39989)
Drug Delivery (177)
Drug Development (91704)
Employer Resources (207)
FDA (18553)
Job Trends (17487)
News (398733)
Policy (40013)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (4)
2027 Genetown Standard (5)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (6)
Academia (3053)
Academic (2)
Accelerated approval (56)
ADA (49)
Adcomms (40)
Allergies (197)
Alliances (56990)
ALS (236)
Alzheimer's disease (1969)
Antibody-drug conjugate (ADC) (552)
Approvals (18895)
Artificial intelligence (868)
ASCO (345)
Autoimmune disease (362)
Automation (64)
Bankruptcy (407)
Best Places to Work (12635)
BIOSECURE Act (23)
Biosimilars (248)
Biotechnology (480)
Bladder cancer (211)
Brain cancer (85)
Breast cancer (838)
Cancer (6578)
Cardiovascular disease (554)
Career advice (3597)
Career pathing (52)
CAR-T (385)
CDC (76)
Celiac Disease (3)
Cell therapy (1071)
Cervical cancer (54)
Clinical research (79009)
Collaboration (2371)
Company closure (8)
Compensation (1512)
Complete response letters (106)
COVID-19 (3041)
CRISPR (124)
C-suite (1285)
Cystic fibrosis (167)
Data (8691)
Decentralized trials (3)
Denatured (91)
Depression (193)
Dermatology (96)
Diabetes (703)
Diagnostics (7599)
Digital health (70)
Diversity (14)
Diversity, equity & inclusion (49)
Drug discovery (425)
Drug pricing (245)
Drug shortages (39)
Duchenne muscular dystrophy (318)
Earnings (102483)
Editorial (78)
Employer branding (25)
Employer resources (174)
Events (138660)
Executive appointments (1192)
FDA (22622)
Fibrodysplasia Ossificans Progressiva (8)
Friedreich's ataxia (19)
Frontotemporal dementia (36)
Funding (1945)
Gene editing (271)
Generative AI (89)
Gene therapy (849)
GLP-1 (1286)
Government (5560)
Grass and pollen (8)
Guidances (420)
Healthcare (21263)
Hematology (198)
HIV (95)
Huntington's disease (64)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (115)
Immunology and inflammation (353)
Immuno-oncology (116)
Indications (206)
Infectious disease (3439)
Inflammatory bowel disease (242)
Inflation Reduction Act (17)
Influenza (148)
Intellectual property (323)
Interviews (821)
IPO (18003)
IRA (61)
Job creations (5209)
Job search strategy (2871)
JPM (73)
Kidney cancer (23)
Labor market (122)
Layoffs (687)
Leadership (53)
Legal (10171)
Liver cancer (111)
Longevity (37)
Lung cancer (873)
Lymphoma (469)
Machine learning (66)
Management (66)
Manufacturing (1221)
MASH (226)
Medical device (15279)
Medtech (15438)
Mergers & acquisitions (23290)
Metabolic disorders (1822)
mRNA (266)
Multiple sclerosis (204)
NASH (24)
Neurodegenerative disease (508)
Neuropsychiatric disorders (126)
Neuroscience (3716)
Neurotech (2)
NextGen: Class of 2026 (7716)
Non-profit (5146)
Now hiring (80)
Obesity (871)
Opinion (374)
Ovarian cancer (244)
Pain (285)
Pancreatic cancer (352)
Parkinson's disease (417)
Partnered (39)
Patents (655)
Patient recruitment (763)
Peanut (70)
People (67999)
Pharmaceutical (136)
Pharmacy benefit managers (37)
Phase 1 (24419)
Phase 2 (34316)
Phase 3 (25808)
Pipeline (9751)
Policy (398)
Postmarket research (3559)
Preclinical (10981)
Press Release (72)
Prostate cancer (347)
Psychedelics (68)
Radiopharmaceuticals (373)
Rare diseases (1262)
Real estate (7462)
Recruiting (81)
Regulatory (30385)
Reports (77)
Research institute (2771)
Resumes & cover letters (654)
Rett syndrome (43)
RNA editing (29)
RSV (98)
Schizophrenia (196)
Series A (327)
Series B (237)
Service/supplier (28)
Sickle cell disease (127)
Special edition (32)
Spinal muscular atrophy (190)
Sponsored (55)
Startups (4372)
State (2)
Stomach cancer (21)
Supply chain (146)
Tariffs (104)
The Weekly (144)
Vaccines (1306)
Venture capital (134)
Weight loss (597)
Women's health (141)
Worklife (24)
Date
Today (100)
Last 7 days (647)
Last 30 days (3211)
Last 365 days (33245)
2026 (16222)
2025 (33218)
2024 (38123)
2023 (42564)
2022 (53928)
2021 (58720)
2020 (57663)
2019 (51334)
2018 (39119)
2017 (37188)
2016 (38329)
2015 (44432)
2014 (39672)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1296)
Alabama (102)
Alaska (7)
Arizona (403)
Arkansas (16)
Asia (52299)
Australia (9193)
California (14377)
Canada (4014)
China (1574)
Colorado (618)
Connecticut (641)
Delaware (443)
Europe (120605)
Florida (2132)
Georgia (467)
Hawaii (4)
Idaho (70)
Illinois (1253)
India (102)
Indiana (663)
Iowa (25)
Japan (593)
Kansas (143)
Kentucky (56)
Louisiana (64)
Maine (89)
Maryland (1744)
Massachusetts (10518)
Michigan (422)
Minnesota (800)
Mississippi (7)
Missouri (164)
Montana (37)
Nebraska (30)
Nevada (153)
New Hampshire (92)
New Jersey (3810)
New Mexico (35)
New York (3783)
North Carolina (1938)
North Dakota (11)
Northern California (7148)
Ohio (449)
Oklahoma (27)
Oregon (55)
Pennsylvania (2832)
Puerto Rico (30)
Rhode Island (54)
South America (1668)
South Carolina (88)
South Dakota (2)
Southern California (5640)
Tennessee (228)
Texas (2343)
United States (51444)
Utah (427)
Vermont (1)
Virginia (364)
Washington D.C. (89)
Washington State (1183)
West Virginia (4)
Wisconsin (160)
Wyoming (2)
There are 883,859 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Novartis RemIND data at EAACI show Rhapsido® potential as first targeted therapy for chronic inducible urticaria (CIndU)
June 12, 2026
·
11 min read
Neurodegenerative disease
Novartis’ $12B Avidity buy pays dividends with Phase 1/2 muscular dystrophy win
The RNA-based medicine is one of a handful of antibody-oligonucleotide conjugates that Novartis acquired last October when it took over neuromuscular-focused Avidity Biosciences.
June 12, 2026
·
2 min read
·
Tristan Manalac
Business
Novo hit with cybersecurity breach, urges vigilance among trial participants
Novo Nordisk said that the information affected by the breach shouldn’t allow third parties to “identify participants in our clinical trials” despite “unauthorized access” to patients’ personal data.
June 12, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Heartseed, World’s First Clinical Trial of Catheter Administration of iPSC-Derived Cardiomyocyte Spheroids: First Patient Dosed
June 12, 2026
·
2 min read
Press Releases
Simcere Pharmaceutical Enters into a Research Collaboration Agreement with Stanford Medicine to Develop Innovative Therapies for Patients with Idiopathic Pulmonary Fibrosis
June 12, 2026
·
3 min read
Press Releases
AbbVie Presents New Data at EHA 2026 Congress for VENCLEXTA®/VENCLYXTO® (venetoclax) in First-Line Chronic Lymphocytic Leukemia Highlighting Long-Term Treatment Outcomes for Patients: Nine-Year Results
June 12, 2026
·
14 min read
Press Releases
Evaxion receives Prix Galien UK Award for Best digital health solution
June 12, 2026
·
4 min read
Insights
Beyond sunshine: Iberia’s biotech moment has arrived with developing capital networks
Strong science, lower costs and growing capital networks are putting Spain and Portugal on the biotech investment map, even as structural bottlenecks persist, according to two investors.
June 12, 2026
·
4 min read
·
Jennifer C. Smith-Parker
Press Releases
CORRECTING and REPLACING Zetagen Therapeutics Presents Phase 2a Results at ASCO for Investigational ZetaMet™ (Zeta BC 003) in Metastatic Breast Cancer Patients with Lytic Bone Lesions
June 12, 2026
·
5 min read
Press Releases
Akeso’s Gumokimab (AK111, Anti-IL-17) Approved by NMPA for Moderate-to-Severe Plaque Psoriasis, Bolstering Its Autoimmune Disease Portfolio
June 12, 2026
·
6 min read
1 of 88,386
Next
